Characterised as IGF-1 resistance, the increase in IGF-1 concentration has been shown in age-related degenerative conditions, such as Alzheimer’s disease and Parkinson’s disease [26,27,28]. Here, IGF1 is linked to early-onset autosomal dominant Alzheimer disease.